SCHEMBL7186901

SCHEMBL7186901

CS(=O)(=O)c1ccccc1-c1ncc[nH]1

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CSNK1A1 P48729 1/20 0.50
TYRO3 Q06418 1/20 0.50
DYRK1B Q9Y463 1/20 0.50
NISCH Q9Y2I1 2/20 0.46
MTOR P42345 1/20 0.46
ADK P55263 1/20 0.46
IDO1 P14902 1/20 0.46
EDNRA P25101 1/20 0.44
ALOX5 P09917 1/20 0.42
ALOX5AP P20292 5/20 0.42
FEN1 P39748 5/20 0.42
HSD11B1 P28845 1/20 0.40
ADRA1A P35348 2/20 0.39
ALDH1A1 P00352 2/20 0.38
KDM4E B2RXH2 1/20 0.38
RAB9A P51151 1/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
TRPV1 Q8NER1 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10425371 0.83 CSNK1A1 (0.54) CSNK1A1TYRO3DYRK1BNISCHMTOR
SCHEMBL9287236 0.78 NISCH (0.64) CSNK1A1TYRO3DYRK1BNISCHMTOR
SCHEMBL9285225 0.77 IDO1 (0.39) CSNK1A1TYRO3DYRK1BNISCHMTOR
SCHEMBL8540682 0.76 CSNK1A1 (0.47) CSNK1A1TYRO3DYRK1BNISCHMTOR
SCHEMBL28219723 0.76 MMP2 (0.45) CSNK1A1TYRO3DYRK1BALDH1A1KDM4E
SCHEMBL14886257 0.76 NISCH (0.61) CSNK1A1TYRO3DYRK1BNISCHMTOR
SCHEMBL10583686 0.75 CSNK1A1 (0.43) CSNK1A1TYRO3DYRK1BNISCHMTOR
SCHEMBL11985512 0.74 CSNK1A1 (0.68) CSNK1A1TYRO3DYRK1BNISCHMTOR
SCHEMBL8617021 0.74 CSNK1A1 (0.44) CSNK1A1TYRO3DYRK1BNISCHMTOR
SCHEMBL674011 0.73 NISCH (0.53) CSNK1A1TYRO3DYRK1BNISCHMTOR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1435956-A2 THERAPEUTIC COMBINATIONS FOR CARDIOVASCULAR AND INFLAMMATORY INDICATIONS Pharmacia Corporation (US) 2004-07-14 EP claimed
WO-2002078626-A2 THERAPEUTIC COMBINATIONS FOR CARDIOVASCULAR AND INFLAMMATORY INDICATIONS PHARMACIA CORPORATION (US) 2002-10-10 WO claimed
EP-0857171-A2 IMIDAZOLE DERIVATIVES AND THE USE THEREOF AS NITROGEN MONOXIDE SYNTHASE INHIBITORS SCHERING AKTIENGESELLSCHAFT (DE) 1998-08-12 EP disclosed
EP-0772600-A1 1,2-SUBSTITUTED IMIDAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1997-05-14 EP disclosed
WO-1997015555-A2 IMIDAZOLE DERIVATIVES AND THE USE THEREOF AS NITROGEN MONOXIDE SYNTHASE INHIBITORS SCHERING AKTIENGESELLSCHAFT (DE) 1997-05-01 WO disclosed
WO-1996003388-A1 1,2-SUBSTITUTED IMIDAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-02-08 WO disclosed